Regulation & Compliance

Brokers Become 'Insurance Distribution Entities': What the IDE, IDP and MII Reset Means When You Appoint a Broker

IRDAI's September 2026 distribution paper would fold brokers, corporate agents, IMFs, web aggregators and OEM brokers into one Insurance Distribution Entity category. Here is what that changes in broker due diligence, and what the July 2026 amendments already require.

Tarun Kumar Singh
Tarun Kumar SinghStrategic Risk & Compliance SpecialistAIII · CRICP · CIAFP
10 min read

Listen to this article

Audio version • 10 min read

insurance distribution entityIRDAI consultationbroker appointmentdue diligenceintermediary regulation

Last reviewed: October 2026

Two different documents, two different levels of certainty

Corporate buyers are now reading about two separate IRDAI moves on intermediaries, and the press coverage tends to blur them. They need to be kept apart, because one is law and the other is a proposal.

The first is the IRDAI (Insurance Intermediaries) (Amendment) Regulations, 2026, reference IRDAI/Reg/8/222/2026, notified on 30 July 2026. It is in force. Among other changes, it requires intermediaries earning more than Rs 10 crore of annual commission to disclose commission, related-party transactions, profits and dividends. It also moved registration from periodic renewal to continuous registration, which is why existing brokers and corporate agents have a re-registration deadline running into early 2027 (covered in our note on the 31 January 2027 re-registration cutover).

The second is the distribution consultation paper reported on 30 September 2026 (Medianama; Mondaq/Tuli & Co). It proposes to rebuild the intermediary categories from the ground up. Brokers, web aggregators, corporate agents, insurance marketing firms (IMFs) and OEM brokers would be folded into a single Insurance Distribution Entity (IDE) category. Agents, PoSPs and other individual salespeople would become Insurance Distribution Persons (IDPs). The paper also proposes a third layer, Market Infrastructure Institutions (MIIs).

The practical question for a risk or procurement head is what changes in broker due diligence if the paper is adopted broadly as drafted, and which of those changes are worth building into appointment letters now.

What the IDE, IDP and MII labels actually mean

The proposal reorganises distribution around what an entity does, rather than which licence history it came from.

  • Insurance Distribution Entity (IDE): the institutional layer. Today's brokers (direct, reinsurance and composite), corporate agents, IMFs, web aggregators and OEM brokers would all sit here. For a corporate buyer, the firm you sign a broker appointment letter with would be an IDE.
  • Insurance Distribution Person (IDP): the individual layer. Agents, PoSPs and other salespeople. IDPs would be closed architecture only, would need a Class 12 minimum qualification, and would need 100 hours of training per segment they sell in (Mondaq/Tuli & Co).
  • Market Infrastructure Institution (MII): a proposed new category for shared platforms, separate from intermediaries. MIIs would be not-for-profit digital platforms promoted by a group of insurers, offering pull-based distribution, with Bima Sugam India Federation cited as an example (Mondaq/Tuli & Co). An MII is not a broker substitute for a placed corporate programme, so it changes little in a broker appointment letter. Our note on Bima Sugam as an MII covers the proposed capital, fee and ownership rules.

For corporate programmes the IDE layer is the one that matters. Your broker relationship, your web aggregator for small retail-adjacent covers, and the corporate agent arm of your bank would all end up in the same bucket. That is a real simplification, but it also means the label on the certificate will stop telling you what kind of business the counterparty runs. A broker and a web aggregator would both read "IDE". Due diligence has to go one level deeper.

If you are already reviewing how IMFs fit into a programme, our piece on the IMF licence model covers the current position, which remains in force until any merger into the IDE category is actually notified.

Capital, deposit and fee norms: what the numbers tell a buyer

The paper proposes a uniform entry and maintenance structure for IDEs (Medianama, 30 September 2026):

  1. Initial capital of Rs 10 lakh.
  2. A bank deposit of 0.1% of previous-year commission and insurance-related income, subject to a minimum of Rs 10 lakh and a maximum of Rs 10 crore.
  3. An application fee of Rs 10,000.
  4. An annual fee of the higher of Rs 10,000 or 0.04% of receipts.

Read these figures carefully. A Rs 10 lakh capital floor is a low bar for an entity that may be placing a multi-crore property and liability programme. The deposit scales with income, but at 0.1% it is a regulatory signal of solvency, not a fund that would make a corporate client whole after a placement error. For an IDE with Rs 50 crore of insurance-related income, the formula gives Rs 5 lakh, so it would post the Rs 10 lakh minimum instead. The Rs 10 crore maximum would only bind at around Rs 10,000 crore of income.

What this means for the buyer

If the entry bar for all distributors converges on the same low number, regulatory capital stops differentiating a large national broker from a small new entrant. The buyer's financial-strength test has to come from elsewhere: audited accounts, the broker's own professional indemnity cover and its limit relative to your programme size, and claims-handling capacity. The deposit figure is still worth asking for, because a firm that cannot tell you what its deposit is under the new formula has probably not done the transition work.

Open versus closed architecture: the conflict question changes shape

The most consequential proposal for corporate buyers is the architecture split. According to Mondaq/Tuli & Co, IDEs could opt for open architecture and distribute non-insurance products, while IDPs would be closed architecture only.

Open architecture for an IDE means two things. First, it can work with multiple insurers, which is already how a broker operates and what a corporate buyer expects. Second, and newer, it can sell products that are not insurance at all. The paper as reported does not list which non-insurance products would be permitted, so buyers should not assume a scope.

Why non-insurance distribution matters to a corporate client

A broker that also earns revenue from distributing other financial or non-financial products to the same client group has a broader set of incentives than one that only earns brokerage and fees on insurance. That is not inherently a problem, but it is a disclosure question that most of today's appointment letters do not address. Three things to ask:

  • Does the IDE operate on open or closed architecture, and has it elected to distribute non-insurance products?
  • If so, does it propose to offer any of them to your group companies, employees or vendors?
  • Is any part of its remuneration from your account linked to a non-insurance product sale?

The closed-architecture rule for IDPs matters mainly for employee benefits and voluntary covers sold at the workplace. An individual IDP tied to one insurer is not giving your employees a market comparison, and the people sitting at an onsite benefits desk should be identified as such.

Revenue disclosure and cost audit: what is already required and what is proposed

Disclosure is where the July regulations and the September paper overlap, and where buyers most often confuse them.

Already in force (July 2026)

Under the Insurance Intermediaries (Amendment) Regulations, 2026 (IRDAI/Reg/8/222/2026), intermediaries with over Rs 10 crore of annual commission must disclose commission, related-party transactions, profits and dividends. Many brokers serving large corporate programmes are likely to clear that threshold. A buyer can ask for these disclosures now.

Proposed (September 2026)

The paper adds two size-based tiers for IDEs (Mondaq/Tuli & Co):

  • IDEs with insurance-related revenue above Rs 50 crore would publicly disclose key accounting parameters, including related-party payments.
  • IDEs with insurance-related revenue above Rs 100 crore would face cost audits.

The difference in the base matters. The July rule keys off commission. The proposed tiers key off insurance-related revenue, which would likely capture fees and other income a broker earns from the insurance business, not only commission. For a buyer, related-party payment disclosure is the most useful data point in either regime: it tells you whether the broker routes money to affiliated surveyors, claims consultants, risk-engineering firms or technology vendors that it then recommends to you.

Ask your broker now for the July 2026 disclosure pack and keep it on the procurement file. When the September proposals are finalised, comparing the two will show you which counterparties were already disclosing at the higher standard.

Rebuilding broker due diligence for the IDE model

Most corporate broker evaluations still lean on licence category, years in business and a reference list. Under a single IDE category, those signals weaken. A sounder due-diligence file has six elements, most of which you can collect under current regulations. Our broker selection RFP guide covers the commercial scoring side; the list below is the regulatory overlay.

  1. Current registration status and transition plan. The broker's present certificate, its re-registration status under the July 2026 amendments, and a written statement of how it expects to be classified if the IDE framework is adopted.
  2. Disclosure pack. The commission, related-party, profit and dividend disclosures required above Rs 10 crore of commission under the July rules.
  3. Business-line map. Which activities the firm and its group carry on: direct broking, reinsurance broking, web aggregation, corporate agency, IMF or OEM broking. After a merger into one IDE category, this map is the only way to see who you are dealing with.
  4. Architecture election. Open or closed, and any non-insurance product distribution.
  5. Staff qualification. For any individual who will service employee-facing covers, whether they would qualify as an IDP under the proposed Class 12 and 100-hour training norms, and whether they are tied to one insurer.
  6. Financial cover for errors. The broker's professional indemnity limit and its claims history, which matter more than the regulatory capital floor.

None of this requires the consultation paper to be final. It requires the buyer to stop treating the licence label as a proxy for the business model.

Checklist for corporate broker-appointment letters

Appointment letters signed in the next two quarters will run into the period when the IDE proposals are either finalised, revised or dropped. Draft them so they work in all three cases. Clauses to add or tighten:

  1. Registration warranty that survives reclassification: the broker warrants it holds, and will keep, valid IRDAI registration under the regulations in force from time to time, including any successor category such as an IDE, and will notify you within a fixed number of days of any change, suspension or condition on that registration.
  2. Disclosure delivery: the broker delivers the commission, related-party, profit and dividend disclosures required under the July 2026 amendments annually, and any additional disclosures required of it under future regulations within a fixed period of their publication.
  3. Related-party declaration: a standing duty to disclose any related-party relationship with a surveyor, loss assessor, risk engineer, TPA, claims consultant or technology vendor it recommends to you, whether or not a regulator requires public disclosure at that revenue tier.
  4. Architecture and non-insurance products: a warranty on its architecture election and a prohibition, or a prior-consent requirement, on marketing non-insurance products to your group, employees or vendors using data obtained under the appointment.
  5. Remuneration transparency: all remuneration received in connection with your account, whether commission, fee or reward from an insurer, to be disclosed by policy and by insurer.
  6. Personnel standards: named service staff, and a commitment that anyone servicing employee covers meets the qualification and training norms that apply to them.
  7. Termination right on regulatory change: a right to terminate without penalty if the broker's regulatory status changes in a way that affects its ability to act for you, or if it elects to distribute non-insurance products you have not approved.
  8. Professional indemnity: a minimum PI limit and a duty to notify any reduction, cancellation or material claim.

For the parallel workstream on TPAs and IRDAI's plan for one set of listing rules across intermediary classes, see our note on the uniform intermediary framework.

What to do this quarter

The September paper is a proposal and may change. The July amendments are binding now. A sensible sequence for a corporate insurance buyer:

  • Now: collect the July 2026 disclosure pack from every broker and corporate agent above the Rs 10 crore commission threshold, and confirm each one's re-registration status.
  • Before FY28 placements: amend appointment-letter templates with the reclassification-proof registration warranty, the related-party declaration and the non-insurance product clause.
  • When the paper is finalised: re-run the business-line map against the final IDE definition, check which counterparties cross the Rs 50 crore disclosure and Rs 100 crore cost-audit thresholds, and update the procurement file.

The structural point is simple. A single IDE category would make the regulator's job easier and make the buyer's job slightly harder, because the certificate would say less about the firm behind it. The answer is a due-diligence file built on what the broker does and how it is paid, which is what the appointment letter should have been testing all along.

About the Author

Tarun Kumar Singh

Tarun Kumar Singh

Strategic Risk & Compliance Specialist

  • AIII
  • CRICP
  • CIAFP
  • Board Advisor, Finexure Consulting
  • Developer of the Behavioural Underinsurance Risk Index (BURI)

Tarun Kumar Singh is a seasoned risk management and insurance professional based in Bengaluru. He serves as Board Advisor at Finexure Consulting, where he advises insurance, fintech, and regulated firms on governance, growth, and trust. His work spans insurance broker regulatory frameworks across India, UAE, and ASEAN, IRDAI compliance and Corporate Agency model reform, VC governance in insurtech, and MSME insurance gap analysis. He is the developer of the Behavioural Underinsurance Risk Index (BURI), a framework applying behavioural economics to underinsurance and insurance fraud risk.

Frequently Asked Questions

Is my broker now an Insurance Distribution Entity?
No. The IDE category exists only in a consultation paper reported on 30 September 2026. Until IRDAI notifies final regulations, your broker remains a registered insurance broker under the existing intermediary regulations, as amended in July 2026.
What disclosures can I ask my broker for today?
Under the Insurance Intermediaries (Amendment) Regulations, 2026 (IRDAI/Reg/8/222/2026), intermediaries with more than Rs 10 crore of annual commission must disclose commission, related-party transactions, profits and dividends. Many brokers handling large corporate programmes are likely to cross that threshold, so ask for the pack.
What is the difference between an IDE and an IDP?
An IDE is the institutional distributor, covering today's brokers, corporate agents, IMFs, web aggregators and OEM brokers. An IDP is an individual seller such as an agent or PoSP. Under the proposal IDPs would be closed architecture only, need a Class 12 qualification and complete 100 hours of training per segment.
Why does open architecture matter to a corporate buyer?
The paper would let IDEs choose open architecture and distribute non-insurance products. A broker earning from other products sold to your group or employees has incentives beyond your insurance programme, so appointment letters should require disclosure of that election and control any marketing to your people.
Should I rewrite my broker appointment letter now?
Yes, but in neutral terms. Use a registration warranty that covers any successor category, require annual delivery of the July 2026 disclosures, add a related-party declaration and a termination right on regulatory change. Do not describe the broker as an IDE until the framework is notified.

Related Glossary Terms

Related Insurance Types

Related Articles

Sarvada Intelligence

Ready to see Sarvada in action?

Explore the platform workflow or start a product conversation with our underwriting automation team.

Explore the platform